Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Becton, Dickinson and Company

BDXB•NYSE
Healthcare
Medical - Instruments & Supplies
$48.16
$0.66(1.39%)
U.S. Market is Open • 14:25

Becton, Dickinson and Company (BDXB) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap13.7B
P/E Ratio29.96
EPS (TTM)$6.33
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$36.97

BDXB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDXB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $36.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.96 and a market capitalization of 13.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
1.39%
3-Month Change
-3.51%
6-Month Change
-3.83%
Year-to-Date (YTD) Change
-4.33%
1-Year Change
-2.63%
3-Year Change
-9.47%
5-Year Change
11.69%
All-Time (Max) Change
11.69%

Contact Information

https://www.bd.com
201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

770,000 Employees
IPO DateMay 21, 2020
CountryUS

Frequently Asked Questions